by Madaline Spencer | Dec 19, 2024
Tanita Allen, a patient advocate with Huntington disease, discusses her diagnostic journey and advocacy work. Huntington’s disease is an inherited condition that causes progressive degeneration of central neurons. It is caused by changes in the HTT gene...
by Madaline Spencer | Dec 18, 2024
Rakesh Jain, MD, MPH, Clinical Professor of Psychiatry, discusses tardive dyskinesia (TD) data from the IMPACT-TD Registry study. TD is a rare neurological disorder characterized by involuntary and repetitive movements, often involving muscles in the...
by Madaline Spencer | Dec 17, 2024
Amy Dickey, MD, Assistant Professor of Medicine at Harvard Medical School, and a patient with erythropoietic porphyria (EPP), discusses the development and testing of a wearable device for light exposure measurements for patients with EPP. EEP is a rare...
by Madaline Spencer | Dec 16, 2024
Megan McLaughlin, Vice President Medicine Development Leader at GSK, discusses data from the GLISTEN phase 3 clinical trial for primary biliary cholangitis (PBC). PBC is a chronic, progressive, autoimmune, liver disease in which the bile ducts become...
by Madaline Spencer | Dec 13, 2024
Susan Dillon, PhD, CEO of Aro Biotherapeutics, discusses the initiation of a phase 1b clinical trial for late onset Pompe disease. Pompe disease is a rare genetic, lysosomal disorder that causes progressive weakness in heart and skeletal muscles. It is...
